10 results on '"b-cell neoplasms"'
Search Results
2. Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction.
- Author
-
Erdem, Simge and Nalçacı, Meliha
- Subjects
- *
CHRONIC lymphocytic leukemia , *PLATELET count , *DISEASE management , *THROMBOCYTOPENIA , *DRUG efficacy - Published
- 2024
- Full Text
- View/download PDF
3. Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period
- Author
-
Hakan Savlı, Ramis Ufuk Akkoyunlu, Naci Çine, Daniil F. Gluzman, Michael P. Zavelevich, Lilia M. Sklyarenko, Stella V. Koval, and Deniz Sünnetçi
- Subjects
chronic lymphocytic leukemia ,non-hodgkin's lymphoma ,b-cell neoplasms ,cancer ,thrombosis ,t-cell neoplasms ,acute leukemia ,myelodysplastic syndromes ,chronic leukemia ,Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
INTRODUCTION: Nuclear factor kappa B (NF-κB) is an important transcription factor in cancer and NF-κB activation has been seen in angiogenesis, tumor progression, and metastasis. Relationships between specific NF-κB gene networks, leukemogenesis, and radiation exposure are still unknown. Our aim was to study the expression levels of the NF-κB1, NF-κB2, and Rel genes in hematological malignancies in the post-Chernobyl period. METHODS: We analyzed gene expression levels of NF- κB1, NF-κB2, and Rel in 49 B-cell chronic lymphocytic leukemia, 8 B-cell non-Hodgkin's lymphoma, 3 acute myeloid leukemia, 3 chronic myeloid leukemia, 2 hairy cell leukemia, 2 myelodysplastic syndrome, and 2 T-cell large granular lymphocytic leukemia patients using realtime polymerase chain reaction. RESULTS: Expression levels of NF-κB1, NF-κB2, and Rel genes were found to be deregulated. DISCUSSION AND CONCLUSION: These results could be accepted as specific gene traces to radiation-induced leukemia or as potential candidates for new diagnostic biomarker studies. Larger experiments and non-exposed control malignant cell populations are needed to clarify these suggestions.
- Published
- 2016
- Full Text
- View/download PDF
4. Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort
- Author
-
Michaël Degaud, Lucile Baseggio, Béatrice Grange, Delphine Manzoni, Sarah Huet, Evelyne Callet-Bauchu, Alexandra Traverse-Glehen, Frédéric Davi, Hervé Ghesquières, Gilles Salles, and Pierre Sujobert
- Subjects
who classification ,lymphocytosis ,b-cell neoplasms ,chronic lymphocytic leukemia ,marginal zone lymphoma ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
According to the World Health Organization (WHO) classification, the nosology of B-cell neoplasms integrates clinical, morphological, phenotypic, and genetic data. In this retrospective analysis, we identified 18 patients with isolated neoplastic lymphocytosis that could not be accurately classified within the WHO classification. Most of them were asymptomatic at the time of diagnosis and the evolution was relatively indolent, as only five patients required treatment after a median follow-up of 48 months. The neoplastic B-cells expressed CD5 in most cases, but the Royal Marsden Hospital score was strictly below 3. Trisomy 12 was the most frequent cytogenetic abnormality. High-throughput sequencing highlighted mutations found in both chronic lymphocytic leukemia (CLL) and marginal zone lymphoma (MZL). Similarly, the immunoglobulin heavy chain variable region repertoire was distinct from those reported in CLL or MZL. However, as treatment choice is dependent on the correct classification of the lymphoproliferative disorder, a histological diagnosis should be performed in case patients need to be treated.
- Published
- 2019
- Full Text
- View/download PDF
5. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
- Author
-
Haberl, Sabine, Haferlach, Torsten, Stengel, Anna, Jeromin, Sabine, Kern, Wolfgang, and Haferlach, Claudia
- Subjects
- *
CHRONIC lymphocytic leukemia , *CANCER genetics , *B cell lymphoma , *MYC oncogenes , *CYTOGENETICS , *KARYOTYPES , *GENETICS - Abstract
A cohort comprising 156 patients with B-cell neoplasms harboring an MYC rearrangement was analyzed with respect to phenotypic presentation, molecular markers ( TP53 , MYC and ID3 ) and additional cytogenetic abnormalities (concomitantly occurring BCL2 , BCL6 and/or CCND1 rearrangements; double, triple or quadruple hit lymphomas = multiple hit lymphomas). MYC translocations occurred as single hit (only MYC rearranged, 63%) or multiple hit lymphoma (37%) and presented as acute leukemia (AL) (14%), Burkitt lymphoma (30%), chronic lymphocytic leukemia (CLL) (21%) or other mature B-cell neoplasms (35%). Multiple hit lymphomas more frequently showed a complex karyotype compared to single hit lymphomas (62% vs. 28%, p < 0.001). Single hit Burkitt lymphomas presented with specific characteristics, by translocation of MYC to an immunoglobulin locus, predominantly a non-complex karyotype (23% vs. 67%, p = 0.012) and a significantly higher ID3 and TP53 mutation frequency ( ID3 mut: 49% vs. 0%, p = 0.002; TP53 mut: 69% vs. 33%, p = 0.045). Additionally, MYC rearranged CLL presented as outstanding group by often showing a non-complex karyotype (85%), absence of ID3 mutations, a high frequency of SF3B1 mutations, and a frequent involvement of non-immunoglobulin loci as MYC- partner genes (61%). Consequently, genetic characteristics distinguish different subgroups of MYC rearranged B-cell neoplasms and therefore may contribute to a new classification system. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period.
- Author
-
Savlı, Hakan, Akkoyunlu, Ramis Ufuk, Çine, Naci, Gluzman, Daniil F., Zavelevich, Michael P., Sklyarenko, Lilia M., Koval, Stella V., and Sünnetçi, Deniz
- Subjects
- *
BLOOD diseases , *CHRONIC lymphocytic leukemia , *GENE expression , *HODGKIN'S disease , *LEUKEMIA , *LYMPHOCYTIC leukemia , *LYMPHOMAS , *MYELODYSPLASTIC syndromes , *POLYMERASE chain reaction , *DNA-binding proteins , *CHRONIC myeloid leukemia , *ACUTE myeloid leukemia , *HEMATOLOGIC malignancies - Abstract
Objective: Nuclear factor kappa B (NF-κB) is an important transcription factor in cancer and NF-κB activation has been seen in angiogenesis, tumor progression, and metastasis. Relationships between specific NF-κB gene networks, leukemogenesis, and radiation exposure are still unknown. Our aim was to study the expression levels of the NF-κB1, NF-κB2, and Rel genes in hematological malignancies in the post-Chernobyl period. Materials and Methods: We analyzed gene expression levels of NFκB1, NF-κB2, and Rel in 49 B-cell chronic lymphocytic leukemia, 8 B-cell non-Hodgkin's lymphoma, 3 acute myeloid leukemia, 3 chronic myeloid leukemia, 2 hairy cell leukemia, 2 myelodysplastic syndrome, and 2 T-cell large granular lymphocytic leukemia patients using realtime polymerase chain reaction. Results: Expression levels of NF-κB1, NF-κB2, and Rel genes were found to be deregulated. Conclusion: These results could be accepted as specific gene traces to radiation-induced leukemia or as potential candidates for new diagnostic biomarker studies. Larger experiments and non-exposed control malignant cell populations are needed to clarify these suggestions. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort
- Author
-
Gilles Salles, Pierre Sujobert, Herve Ghesquieres, Béatrice Grange, Delphine Manzoni, Sarah Huet, Frederic Davi, Michaël Degaud, Alexandra Traverse-Glehen, Lucile Baseggio, and Evelyne Callet-Bauchu
- Subjects
0301 basic medicine ,Nosology ,Cancer Research ,Pathology ,medicine.medical_specialty ,Lymphocytosis ,Chronic lymphocytic leukemia ,B-cell neoplasms ,lymphocytosis ,Asymptomatic ,lcsh:RC254-282 ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,WHO classification ,business.industry ,Retrospective cohort study ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,marginal zone lymphoma ,030104 developmental biology ,Oncology ,Monoclonal ,chronic lymphocytic leukemia ,medicine.symptom ,CD5 ,business ,Trisomy ,030215 immunology - Abstract
According to the World Health Organization (WHO) classification, the nosology of B-cell neoplasms integrates clinical, morphological, phenotypic, and genetic data. In this retrospective analysis, we identified 18 patients with isolated neoplastic lymphocytosis that could not be accurately classified within the WHO classification. Most of them were asymptomatic at the time of diagnosis and the evolution was relatively indolent, as only five patients required treatment after a median follow-up of 48 months. The neoplastic B-cells expressed CD5 in most cases, but the Royal Marsden Hospital score was strictly below 3. Trisomy 12 was the most frequent cytogenetic abnormality. High-throughput sequencing highlighted mutations found in both chronic lymphocytic leukemia (CLL) and marginal zone lymphoma (MZL). Similarly, the immunoglobulin heavy chain variable region repertoire was distinct from those reported in CLL or MZL. However, as treatment choice is dependent on the correct classification of the lymphoproliferative disorder, a histological diagnosis should be performed in case patients need to be treated.
- Published
- 2019
- Full Text
- View/download PDF
8. Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period
- Author
-
S V Koval, Naci Cine, Hakan Savli, L M Sklyarenko, D F Gluzman, Ramis Ufuk Akkoyunlu, Deniz Sünnetçi, and M P Zavelevich
- Subjects
0301 basic medicine ,Male ,Neoplasms, Radiation-Induced ,Lymphoma ,Chronic lymphocytic leukemia ,Large granular lymphocytic leukemia ,0302 clinical medicine ,hemic and lymphatic diseases ,Cancer ,Leukemia, Radiation-Induced ,NF-kappa B ,Myeloid leukemia ,lcsh:Diseases of the blood and blood-forming organs ,Hematology ,Middle Aged ,Chronic leukemia ,B-Cell neoplasms ,Leukemia ,030220 oncology & carcinogenesis ,T-cell neoplasms ,Female ,Ukraine ,Research Article ,Adult ,lcsh:Internal medicine ,Myelodysplastic syndromes ,Real-Time Polymerase Chain Reaction ,03 medical and health sciences ,Young Adult ,NF-kappa B p52 Subunit ,medicine ,Humans ,Hairy cell leukemia ,lcsh:RC31-1245 ,Aged ,Acute leukemia ,lcsh:RC633-647.5 ,business.industry ,Transcription Factor RelA ,NF-kappa B p50 Subunit ,Thrombosis ,medicine.disease ,non-Hodgkin’s lymphoma ,030104 developmental biology ,Chernobyl Nuclear Accident ,Immunology ,Cancer research ,Genes, rel ,REL ,business - Abstract
Nuclear factor kappa B (NF-κB) is an important transcription factor in cancer and NF-κB activation has been seen in angiogenesis, tumor progression, and metastasis. Relationships between specific NF-κB gene networks, leukemogenesis, and radiation exposure are still unknown. Our aim was to study the expression levels of the NF-κB1, NF-κB2, and Rel genes in hematological malignancies in the post-Chernobyl period.We analyzed gene expression levels of NF-κB1, NF-κB2, and Rel in 49 B-cell chronic lymphocytic leukemia, 8 B-cell non-Hodgkin's lymphoma, 3 acute myeloid leukemia, 3 chronic myeloid leukemia, 2 hairy cell leukemia, 2 myelodysplastic syndrome, and 2 T-cell large granular lymphocytic leukemia patients using real-time polymerase chain reaction.Expression levels of NF-κB1, NF-κB2, and Rel genes were found to be deregulated.These results could be accepted as specific gene traces to radiation-induced leukemia or as potential candidates for new diagnostic biomarker studies. Larger experiments and non-exposed control malignant cell populations are needed to clarify these suggestions.Amaç: Nükleer faktör kappa B (NF-κB), kanserde önemli bir transkripsiyon faktörü olup aktivasyonu anjiyogenez, tümör gelişimi ve metastazın birçok basamağında görülmektedir. Spesifik NF-κB gen ağları, lökomogenez ve radyasyon maruziyeti arasındaki ilişki halen belirsizdir. Çalışmamızda Çernobil sonrası hematolojik kanserlerde NF-κB1, NF-κB2 ve Rel genlerinin ekspresyon düzeylerini incelemeyi amaçladık. Gereç ve Yöntemler: Gerçek zamanlı polimeraz zincir reaksiyonu ile 49 B-hücreli kronik lenfositik lösemi, 8 B-hücreli non-Hodgkin lenfoma, 3 akut myeloid lösemi, 3 kronik myeloid lösemi, 2 tüylü hücre lösemi, 2 miyelodisplastik sendrom ve 2 T-hücreli büyük granüler lenfositik lösemi hastasında NF-κB1, NF-κB2 ve Rel gen ekspresyon düzeylerini analiz ettik. Bulgular: NF-κB1, NF-κB2 ve Rel genlerine ait ekspresyon düzeyleri değişmiş olarak saptandı. Sonuç: Bu sonuçlar, radyasyonla indüklenmiş lösemilerdeki spesifik gen izleri veya yeni tanısal biyobelirteç çalışmalarına muhtemel aday önerileri olarak da kabul edilebilir. Bu düşünceleri açıklığa kavuşturmak için daha geniş deneyler ve radyasyon maruziyeti olmayan kontrol malign hücre popülasyonlarına ihtiyaç vardır.
- Published
- 2016
9. Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort.
- Author
-
Degaud, Michaël, Baseggio, Lucile, Grange, Béatrice, Manzoni, Delphine, Huet, Sarah, Callet-Bauchu, Evelyne, Traverse-Glehen, Alexandra, Davi, Frédéric, Ghesquières, Hervé, Salles, Gilles, and Sujobert, Pierre
- Subjects
- *
CHRONIC lymphocytic leukemia diagnosis , *CHRONIC lymphocytic leukemia treatment , *B cell lymphoma , *CHRONIC lymphocytic leukemia , *PATIENT aftercare , *IDENTIFICATION , *IMMUNOGLOBULINS , *LONGITUDINAL method , *GENETIC mutation , *PATIENTS , *HIGH throughput screening (Drug development) , *DOWN syndrome , *RETROSPECTIVE studies - Abstract
According to the World Health Organization (WHO) classification, the nosology of B-cell neoplasms integrates clinical, morphological, phenotypic, and genetic data. In this retrospective analysis, we identified 18 patients with isolated neoplastic lymphocytosis that could not be accurately classified within the WHO classification. Most of them were asymptomatic at the time of diagnosis and the evolution was relatively indolent, as only five patients required treatment after a median follow-up of 48 months. The neoplastic B-cells expressed CD5 in most cases, but the Royal Marsden Hospital score was strictly below 3. Trisomy 12 was the most frequent cytogenetic abnormality. High-throughput sequencing highlighted mutations found in both chronic lymphocytic leukemia (CLL) and marginal zone lymphoma (MZL). Similarly, the immunoglobulin heavy chain variable region repertoire was distinct from those reported in CLL or MZL. However, as treatment choice is dependent on the correct classification of the lymphoproliferative disorder, a histological diagnosis should be performed in case patients need to be treated. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms
- Author
-
M. De Carvalho Bittencourt, Véronique Latger-Cannard, Jean-François Lesesve, S. Tardy, B. Frotscher, Pierre Feugier, Service d’Hématologie Clinique [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Immunologie [CHRU Nancy], Centre de Recherche en Automatique de Nancy (CRAN), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), and Centre National de la Recherche Scientifique (CNRS)-Université de Lorraine (UL)
- Subjects
Pathology ,[SDV]Life Sciences [q-bio] ,Chronic lymphocytic leukemia ,Clinical Biochemistry ,Mature B-Cell ,Gene Expression ,Lymphoma, Mantle-Cell ,0302 clinical medicine ,Immunophenotyping ,hemic and lymphatic diseases ,Receptors, Immunologic ,Lymphoma, Follicular ,Characteristic morphology ,Aged, 80 and over ,0303 health sciences ,B-Lymphocytes ,Leukemia, Hairy Cell ,medicine.diagnostic_test ,Hematology ,General Medicine ,Middle Aged ,3. Good health ,030220 oncology & carcinogenesis ,Adult ,medicine.medical_specialty ,B-cell neoplasms ,Lymphocytosis ,GPI-Linked Proteins ,Flow cytometry ,Diagnosis, Differential ,03 medical and health sciences ,immunophenotyping ,Antigens, CD ,Predictive Value of Tests ,medicine ,Biomarkers, Tumor ,Humans ,030304 developmental biology ,Aged ,business.industry ,Biochemistry (medical) ,Cytogenetics ,Gold standard (test) ,Lymphoma, B-Cell, Marginal Zone ,medicine.disease ,Leukemia, Lymphocytic, Chronic, B-Cell ,ROC Curve ,CD200 ,Case-Control Studies ,Differential diagnosis ,CD160 ,business ,CLL - Abstract
SummaryIntroduction Chronic lymphocytic leukemia is usually diagnosed through the characteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in diagnostic uncertainty. Methods Using flow cytometry analysis, we investigated the expression of CDs160/200 on B cells from 124 patients (82 CLL, 42 other B-cell neoplasms) and nine controls. CDs160/200 measurements were determined as a ratio of the mean fluorescence intensities of leukemic cells/controls and were considered positive when the ratios were ≥2 and 20, respectively. Results Sixty and 83% CLL expressed CDs160/200 as compared to 5% and 10% of other B-cell neoplasms, respectively. None of the controls showed CDs160/200 expressions. Combination of both markers was observed in 55% of CLL but only in 2% of other B-cell neoplasms, and absence of both markers occurred in 12% of CLL but in 86% of other B-cell neoplasms. Conclusion CDs160/200 were associated with markers of the gold standard ‘Matutes score’ and could be useful markers to differentiate atypical CLL from other B-cell neoplasms in the absence of available biopsies or cytogenetics and molecular studies.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.